The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
In article number 1707365, Patrick Couvreur, Christian Serre, and co‐workers evaluate the biomedical applications of metal–organic frameworks at the preclinical stage, for pharmacological applications or toxicity evaluation. Current surface‐engineering approaches, in vivo studies, and their prospects are considered. The back cover image illustrates the circulation of drug‐loaded MOF nanoparticles...
In the past few years, numerous studies have demonstrated the great potential of nano particles of metal‐organic frameworks (nanoMOFs) at the preclinical level for biomedical applications. Many of them were reported very recently based on their bioactive composition, anticancer application, or from a general drug delivery/theranostic perspective. In this review, the authors aim at providing a global...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.